Medpace Holdings, Inc. (MEDP)
620.03
-0.72
(-0.12%)
USD |
NASDAQ |
Aug 24, 16:00
619.80
-0.23
(-0.04%)
Pre-Market: 08:18
Medpace Holdings Enterprise Value : 16.90B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 16.90B |
| August 21, 2026 | 16.92B |
| August 20, 2026 | 16.70B |
| August 19, 2026 | 16.58B |
| August 18, 2026 | 16.08B |
| August 17, 2026 | 16.27B |
| August 14, 2026 | 15.75B |
| August 13, 2026 | 15.84B |
| August 12, 2026 | 16.26B |
| August 11, 2026 | 16.50B |
| August 10, 2026 | 16.41B |
| August 07, 2026 | 16.09B |
| August 06, 2026 | 15.93B |
| August 05, 2026 | 16.00B |
| August 04, 2026 | 15.65B |
| August 03, 2026 | 15.60B |
| July 31, 2026 | 15.71B |
| July 30, 2026 | 15.74B |
| July 29, 2026 | 15.93B |
| July 28, 2026 | 15.54B |
| July 27, 2026 | 16.05B |
| July 24, 2026 | 16.38B |
| July 23, 2026 | 16.51B |
| July 22, 2026 | 14.34B |
| July 21, 2026 | 14.44B |
| Date | Value |
|---|---|
| July 20, 2026 | 14.34B |
| July 17, 2026 | 14.61B |
| July 16, 2026 | 14.62B |
| July 15, 2026 | 14.38B |
| July 14, 2026 | 14.57B |
| July 13, 2026 | 14.40B |
| July 10, 2026 | 14.63B |
| July 09, 2026 | 14.55B |
| July 08, 2026 | 14.45B |
| July 07, 2026 | 14.85B |
| July 06, 2026 | 15.37B |
| July 02, 2026 | 15.17B |
| July 01, 2026 | 14.77B |
| June 30, 2026 | 14.39B |
| June 29, 2026 | 14.73B |
| June 26, 2026 | 14.51B |
| June 25, 2026 | 14.31B |
| June 24, 2026 | 14.10B |
| June 23, 2026 | 12.98B |
| June 22, 2026 | 12.48B |
| June 18, 2026 | 12.60B |
| June 17, 2026 | 12.52B |
| June 16, 2026 | 12.64B |
| June 15, 2026 | 12.81B |
| June 12, 2026 | 12.81B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 57.13B |
| Charles River Laboratories International, Inc. | 17.12B |
| Avantor, Inc. | 13.04B |
| Champions Oncology, Inc. | 68.87M |
| Personalis, Inc. | 1.640B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 121.36M |
| Revenue (Quarterly) | 707.33M |
| Total Expenses (Quarterly) | 585.97M |
| EPS Diluted (Quarterly) | 4.250 |
| Gross Profit Margin (Quarterly) | 27.56% |
| Profit Margin (Quarterly) | 17.16% |
| Earnings Yield | 2.75% |
| Operating Earnings Yield | 3.26% |
| Normalized Earnings Yield | 2.750 |